GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Parnell Pharmaceuticals Holdings Ltd (OTCPK:PARNF) » Definitions » Additional Paid-In Capital

Parnell Pharmaceuticals Holdings (Parnell Pharmaceuticals Holdings) Additional Paid-In Capital : $45.53 Mil(As of Dec. 2018)


View and export this data going back to 2014. Start your Free Trial

What is Parnell Pharmaceuticals Holdings Additional Paid-In Capital?


Parnell Pharmaceuticals Holdings's quarterly additional paid-in capital increased from Dec. 2016 ($46.67 Mil) to Dec. 2017 ($48.56 Mil) but then stayed the same from Dec. 2017 ($48.56 Mil) to Dec. 2018 ($45.53 Mil).

Parnell Pharmaceuticals Holdings's annual additional paid-in capital increased from Dec. 2016 ($46.67 Mil) to Dec. 2017 ($48.56 Mil) but then declined from Dec. 2017 ($48.56 Mil) to Dec. 2018 ($45.53 Mil).

Parnell Pharmaceuticals Holdings Additional Paid-In Capital Historical Data

The historical data trend for Parnell Pharmaceuticals Holdings's Additional Paid-In Capital can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Parnell Pharmaceuticals Holdings Additional Paid-In Capital Chart

Parnell Pharmaceuticals Holdings Annual Data
Trend Jun12 Jun13 Jun14 Dec15 Dec16 Dec17 Dec18
Additional Paid-In Capital
Get a 7-Day Free Trial 51.82 - 46.67 48.56 45.53

Parnell Pharmaceuticals Holdings Semi-Annual Data
Jun12 Jun13 Jun14 Dec15 Dec16 Dec17 Dec18
Additional Paid-In Capital Get a 7-Day Free Trial 51.82 - 46.67 48.56 45.53

Parnell Pharmaceuticals Holdings Additional Paid-In Capital Calculation

Capital that a company raises in a financing round in excess of the capital's par value. The account represents the excess paid by an investor over the par-value price of a stock issue. Additional paid-in-capital can arise from issuing either preferred or common stock.

Additional Paid-In Capital is calculated as

Additional Paid-In Capital=(Issue Price-Par Value)* Shares Outstanding (Diluted Average)

Parnell Pharmaceuticals Holdings Additional Paid-In Capital Related Terms

Thank you for viewing the detailed overview of Parnell Pharmaceuticals Holdings's Additional Paid-In Capital provided by GuruFocus.com. Please click on the following links to see related term pages.

Parnell Pharmaceuticals Holdings (Parnell Pharmaceuticals Holdings) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Parnell Pharmaceuticals Holdings Ltd (OTCPK:PARNF) » Definitions » Additional Paid-In Capital
Comparable Companies
OWCP CXUS CANB CNABQ LITH APPB GSRX PCYN EVIO GENH ZTS TSE:4502 XTER:MRK HKSE:03692 TSE:4523 SZSE:000661 TSE:4507 SZSE:000538 NSE:SUNPHARMA SZSE:300601
Traded in Other Exchanges
N/A
Address
476 Gardeners Road, Unit 4, Century Estate, Alexandria, Sydney, NSW, AUS, 2015
Website
https://www.parnell.com
Parnell Pharmaceuticals Holdings Ltd is an Australia based veterinary pharmaceutical company. It is focused on developing, manufacturing and commercializing animal health solutions. The group manufactures and market products for companion animals and production animals. The firm also has a pipeline of drug products like Zydax, PAR121 and PAR122 and Luminous which covers therapeutic areas in orthopedics, dermatology, and nutraceuticals. The operating segments of the company are Companion animal, Production animal - U.S., Production animal - rest of world and Contract Manufacturing. It operates internationally and generates the majority of the revenue from the Production animal - U.S. segment which covers the group's reproductive hormone portfolio across production animal in the USA.